CD8A and breast cancer: The accumulation of arachidonic acid in MDSCs leads to increased biosynthesis of prostaglandin E2, which mediates MDSC differentiation through E-prostanoid 1/2/4 receptor and inhibits antigen-specific activation of CD4+T cells and CD8+T cells, thus promoting BC progression.